pharmaceutical investing Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET®
pharmaceutical investing Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET (Avatrombopag)
Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development